Article
Integrative Analysis of Gene Expression Based on Multi-Omics Databases Identified CXC Chemokines as Immune Prognostic Biomarkers of Rectal Adenocarcinoma
2021-05-04
Abstract excerpt
<h4>Background: </h4> Rectal adenocarcinoma (READ) is one of the most frequent malignancies with a high recurrence rate. CXC chemokines, as indispensable components of the immune system, are considered broadly involving in tumorigenesis by orchestrating the immune cell chemotaxis and thus affect the prognosis of READ patients. However, the values of CXC chemokines as prognostic biomarkers and potential regulatory...
Topics
Open a Topic to create a Post that cites this publication.
- Bladder and Urothelial Cancer Treatments
- Cancer Immunotherapy and Biomarkers
- Cancer, Stress, Anesthesia, and Immune Response
- Chemokine receptors and signaling
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Colorectal Cancer Treatments and Studies
- Ferroptosis and cancer prognosis
- Genetic factors in colorectal cancer
Identifiers and source
- Literature Corpus work
- e46123f2-5eeb-5c6e-838f-d52069a7084d
- DOI
- 10.21203/rs.3.rs-447142/v1